Author name: Lynne Doty

Lynne Doty is a news writer for politics, health, business, parenting, and finance. Lynne is an avid runner and enjoys spending time with her kids—who are both competitive swimmers—and her husband.

Avatar of Lynne Doty
report card comments 1 1

168 Report Card Comments, Plus Writing Tips (Free Printables)

Writing report card comments can be a real chore, but they’re an important way to communicate with parents and students. We’ve got dozens of report card comments for students at every level: emerging, developing, proficient, and extending standards, plus comments that address behavior, social skills, and more. Jump to: FREE PRINTABLE Get a free printable […]

168 Report Card Comments, Plus Writing Tips (Free Printables) Read More »

author info

Blog Tour for The Legendary Scarlett & Browne by Jonathan Stroud (promo)

Welcome to my stop on the blog tour for The Legendary Scarlett & Browne by Jonathan Stroud. This tour is being hosted by TBR and Beyond Tours. The Legendary Scarlett & Browne (The Outlaws Scarlett and Browne #3) by Jonathan Stroud Genre: Young Adult Science Fiction/Fantasy Publishing Date: March 25, 2025 The death-defying conclusion to the “audacious,” “razor-sharp,”

Blog Tour for The Legendary Scarlett & Browne by Jonathan Stroud (promo) Read More »

108014612 1722461512998 gettyimages 1248003077 SXSW 2023

23andMe files for bankruptcy, Anne Wojcicki steps down as CEO

Embattled genetic testing company 23andMe, once valued at $6 billion, filed for Chapter 11 bankruptcy protection in Missouri federal court on Sunday night. The company’s CEO, Anne Wojcicki, has resigned from her role as chief executive effective immediately, though she will remain a member of the board. Joseph Selsavage, 23andMe’s chief financial and accounting officer,

23andMe files for bankruptcy, Anne Wojcicki steps down as CEO Read More »

107388672 1710764847941 gettyimages 2092473213 dsc01895copy 8zcnfedn

Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer

Patients, doctors and investors will soon learn a lot more about a new, more convenient treatment that could shake up the booming weight loss drug market. Eli Lilly plans to release initial results from several late-stage clinical trials on its experimental once-daily obesity pill, orforglipron, this year. The company has said it expects to unveil

Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer Read More »

108109365 17407747232025 02 27t072312z 509763262 rc2u2dary9x4 rtrmadp 0 pope francis health

Pope Francis to be released from the hospital

Pope Francis is scheduled to be discharged from the hospital on Sunday, his doctors at Gemelli Hospital said. Francis, 88, was hospitalized for bronchitis on Feb. 14 and remained under care for more than five weeks. At times, the pope was in critical condition and required high-flow oxygen therapy, according to the Vatican, and his changing health status captivated the world’s

Pope Francis to be released from the hospital Read More »

107378853 1709040141961 gettyimages 1665778558 img 5416 1

Zepbound copycats remain online despite FDA ban

This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly‘s weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn’t look like much has changed.  Popular websites like Amble, EllieMD, Willow and Mochi Health are all still advertising versions of tirzepatide, the active ingredient in Zepbound. Some,

Zepbound copycats remain online despite FDA ban Read More »

Scroll to Top